MILPITAS, CA. March 5, 2019 – MagArray, the leading developer of advanced medical diagnostics using magnetic nanosensor technology, announced the prestigious selection of our late-breaking abstract for presentation at ATS 2019.

After a rigorous peer review process, “Novel Multiplexed Plasma Biomarkers and Clinical Factors Augment Risk Assessment for Indeterminate Pulmonary Nodules in Former Smokers” will be presented on Tuesday, May 21, 2019, from 2:15p-4:15p CST.  Our cutting-edge research will be discussed during THE FUTURE OF LUNG CANCER BIOMARKERS: WHERE SHOULD WE LOOK?.  This important session will be moderated by Drs. Joachim G. Aerts (Erasmus MC, Rotterdam, Netherlands), Mark M. Fuster, (VA San Diego Healthcare System & UCSD Medical Center, San Diego, CA) and Anne Valerie Gonzalez, MD, MSc (MUHC Research Institute, Montreal, Canada).

“It is a tremendous honor that our research on a novel, proteomic assay for lung nodule characterization has been selected by the esteemed reviewers at ATS 2019”, said Luis Carbonell, CEO of MagArray.  Most of the 1.5 million indeterminate pulmonary nodules found annually on chest CT are benign.  As a result, there are safety concerns about potential complications from diagnostic procedures, the financial and infrastructural burden of diagnostic follow-up from false-positive screens, and the undue anxiety and center-treatment associated morbidity for asymptomatic indolent tumors.  Plasma protein biomarkers, such as the assay described herein, may be particularly important in helping to select those patients appropriate for serial surveillance by further enhancing the quantitative, noninvasive assessment of these nodules.”

The MagArray CLIA-certified laboratory is prepared to process orders of the REVEAL test from clinicians and reference laboratories. Clinicians and patients interested in gaining access to REVEAL should email amanda.fish@magarray.com or request information from the company’s website at www.magarray.com

About MagArray, Inc.: Founded by a team of professors from Stanford University and located in Milpitas, CA, MagArray has developed a simple, ultra-sensitive, and multiplex system for developing and processing medical diagnostics. Derived from magnetic technologies used in the computer disk drive industry, the MagArray system features many unique advantages over the current industry-leading technologies. MagArray has received past support from the National Cancer Institute’s SBIR program as well as from private investors.

About the ATS: The mission of the American Thoracic Society is to improve health worldwide by advancing research, clinical care, and public health in respiratory disease, critical illness, and sleep disorders.  Its membership consists of more than 16,000 physicians, research scientists, and nurses and other allied healthcare professionals (32 percent of whom work outside the United States).

At the heart of the ATS educational mission is the International Conference. There, thousands of research and clinical experts gather annually to share the latest in science and research in the fields of pulmonary, critical care, and sleep medicine. The ATS International Conference is truly where today’s science meets tomorrow’s care.